Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 38306592

Continuous PEGasparaginase Dosing Reduces Hypersensitivity Reactions in Pediatric ALL: A Dutch Childhood Oncology Group ALL11 Randomized Trial.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
J Clin Oncol
Publication date
2024 May 10
First author
van der Sluis IM

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships

    Authors and identifiers

    1. name
      van der Sluis IM
      type
      Author
    2. name
      Brigitha LJ
      type
      Author
    3. name
      Fiocco M
      type
      Author
    4. name
      de Groot-Kruseman HA
      type
      Author
    5. name
      Bierings M
      type
      Author
    6. name
      van den Bos C
      type
      Author
    7. name
      de Haas V
      type
      Author
    8. name
      Hoogerbrugge PM
      type
      Author
    9. name
      Tissing WJE
      type
      Author
    10. name
      Veening MA
      type
      Author
    11. name
      Pieters R
      type
      Author
    Complete bibliographic record and source provenance
    authors
    1. name
      van der Sluis IM
      type
      Author
    2. name
      Brigitha LJ
      type
      Author
    3. name
      Fiocco M
      type
      Author
    4. name
      de Groot-Kruseman HA
      type
      Author
    5. name
      Bierings M
      type
      Author
    6. name
      van den Bos C
      type
      Author
    7. name
      de Haas V
      type
      Author
    8. name
      Hoogerbrugge PM
      type
      Author
    9. name
      Tissing WJE
      type
      Author
    10. name
      Veening MA
      type
      Author
    11. name
      Pieters R
      type
      Author
    bibliography ids
    1. nci-bib-dc9506f51e2149d788ce22dd
    book metadata
    content sha256
    722cc0b21e1d594ac086cb37e7e045516ab2bb3b36145d0e0e726b702095cded
    document type
    citation
    dois
    1. 10.1200/JCO.23.01797
    electronic publication date
    display
    2024 Feb 2
    precision
    day
    year
    2024
    evidence scope
    bibliographic_metadata_only
    id
    pubmed:38306592
    immutable id
    pubmed:38306592@722cc0b21e1d594ac086cb37e7e045516ab2bb3b36145d0e0e726b702095cded
    journal
    abbreviation
    J Clin Oncol
    issn electronic
    1527-7755
    issn print
    0732-183X
    issue
    14
    name
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology
    nlm unique id
    8309333
    pages
    1676-1686
    volume
    42
    languages
    1. eng
    notices
    absence is not clearance
    true
    has correction metadata
    false
    has expression of concern metadata
    false
    has retraction in link
    false
    pubmed marks article retracted
    false
    pubmed marks retraction notice
    false
    relationships
      outcomes validated
      false
      pmid
      38306592
      provenance
      batch id
      6d213eecf21b6b7867cb
      provider
      NCBI PubMed ESummary
      record sha256
      b7bddc023e6a241b3321b68ddcd6f246473e35bd52a6cb199896175cc594f13c
      response sha256
      684f894a21d8f5f78a3bd0acd8ee4215ff94144487c53dab1056650ee8d6751d
      retrieved at
      2026-09-09T23:48:19.049083+00:00
      publication date
      display
      2024 May 10
      precision
      day
      year
      2024
      publication types
      1. Journal Article
      2. Randomized Controlled Trial
      3. Research Support, Non-U.S. Gov't
      4. Multicenter Study
      record status
      PubMed - indexed for MEDLINE
      schema version
      1.0
      source url
      https://pubmed.ncbi.nlm.nih.gov/38306592/
      title
      Continuous PEGasparaginase Dosing Reduces Hypersensitivity Reactions in Pediatric ALL: A Dutch Childhood Oncology Group ALL11 Randomized Trial.

      Preserved source evidence · Not medical advice